CTOs on the Move

McKesson

www.mckesson.com

 
McKesson Corporation, currently ranked 7th on the FORTUNE 500, we are a global healthcare services and medical supply company dedicated to delivering better care. We support the entire healthcare system, including pharmacies, hospitals, health systems, biotech and life sciences companies, specialty care and oncology practices, physician offices, surgery centers, and long-term care and home health facilities. We deliver pharmaceutical products, medical supplies and business services to each of these groups to create a world of better health.
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion
  • www.mckesson.com
  • One Post Street
    San Francisco, CA USA 94104
  • Phone: 415.983.8300

Executives

Name Title Contact Details
Chandra Pydi
Vice President, IT Portfolio Management Profile
Chris Walzer
Vice President & CIO, SPMR Profile
Kallie Smith
Director, Cyber Security at McKesson Profile
Tiffany Chisum
Director of Information Security Profile
Olanrewaju Oluleye
Senior Manager, Cyber Fraud Defense Profile

Similar Companies

SPI Pharma

SPI Pharma is a New Castle, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Auburn Pharmaceutical

Auburn Pharmaceutical is a national full line generics wholesaler that purchases all of its products directly from 100+ manufacturers and is licensed across the Continental United States.

X4 Pharmaceuticals

X4 Pharmaceuticals (Nasdaq: XFOR) is developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases, including primary immunodeficiencies and certain cancers. The company`s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. X4`s most advanced product candidate, mavorixafor (X4P-001), is in a global Phase 3 pivotal trial in patients with WHIM syndrome, a rare, inherited, primary immunodeficiency disease, and is currently also under investigation in combination with axitinib in the Phase 2a portion of an open-label Phase 1/2 clinical trial in clear cell renal cell carcinoma (ccRCC). X4 is also planning to commence clinical trials of mavorixafor in Severe Congenital Neutropenia (SCN) and Waldenström`s macroglobulinemia (WM) in 2019. The company was founded and is led by a team with extensive biopharmaceutical product development and commercialization expertise and is committed to advancing the development of innovative medicines on behalf of patients with limited treatment options. X4 is a global company that is headquartered in Cambridge, Massachusetts with research offices based in Vienna, Austria.

Vitality

Vitality is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mighty Oak Medical

Navigate. Dont complicate.™ Personalized patient-specific spine care starts here. Navigate. Dont complicate.™ Personalized patient-specific spine care starts here. Mighty Oak Medical named Solution Provider